Grifols’ Annus Horribilis Has Analysts and Short Sellers Divided
Spanish drugmaker Grifols SA is poised for its worst year on record, but some analysts aren’t ready yet to give…
7,055€
1,00%
Echtzeit-Aktienkurs GRIFOLS SA PREF. B EO-,05
Bid:
Ask:
Nachrichten zur GRIFOLS SA PREF. B EO-,05 Aktie
SEC Drops Probe Into Gotham Over Report on Grifols’ Accounts
The US dropped its investigation into General Industrial Partners LLP, the parent company of Gotham City Research, which accused drug…
The High-Powered Lawyer Behind the Grifols Group’s Rise and Fall
For hedge fund Mason Capital Management LLC, much of what ails Grifols SA can be laid at the door of…
Why Is Spanish Healthcare Grifols Stock Trading Lower On Friday?
On Wednesday, Grifols SA (NASDAQ:GRFS) said it ended discussions with Brookfield Capital Partners (UK) Limited about a potential acquisition. This…
Grifols In Talks to Refinance Debt, Credit Line, CEO Says
The embattled Spanish drugmaker Grifols SA is in talks with banks to refinance bonds due next year and extend a…
Brookfield Is Said to Plan to Walk Away From Grifols Bid
Brookfield Asset Management Ltd. is preparing to walk away from a plan to acquire Grifols SA over disagreements on valuation…
Banks to Pitch Roughly €11 Billion Buyout Debt Deal for Grifols
Banks are getting ready to submit final offers to Brookfield Asset Management for a debt package of about €11 billion…
Brookfield to Request More Time for Grifols Due Diligence
Brookfield Asset Management will request more time to conduct due diligence on Grifols SA, as it seeks to take the…
Grifols Investor Group With 7.7% Holding Seeks Seat on Board
A group of Grifols SA investors including Flat Footed LLC, Mason Capital Management LLC and Sachem Head Capital Management LP…
Grifols Seeks Adviser to Help Deal With Minority Shareholders
Spanish drugmaker Grifols SA, the target of a short-seller attack earlier in the year, is seeking to hire an external…
Grifols Holders Call on Family, Brookfield to Offer ‘Fair Price’
Some large Grifols SA shareholders are increasing pressure on the Spanish blood plasma firm to seek a substantial premium in…
Brookfield Seeks Close to €10 Billion Debt for Grifols Bid
Brookfield Asset Management is asking banks to backstop up to €9.5 billion ($10.6 billion) of debt for its potential take-private…
Grifols’ New Auditor Discovers Non-Cash Accounting Discrepancy Linked to China Stake
Spain’s Grifols SA is set to report an unexpected accounting adjustment related to its stake in Shanghai RAAS, according to…
Grifols Shareholder Scranton Reported to Seek Loan from Oaktree
Scranton Enterprises, a major shareholder of Spanish pharmaceutical company Grifols SA, is in talks with Oaktree Capital Management for a…
Short Seller Gains on Grifols Bet That Tripped Elliott Spinout
A well-publicized short bet by General Industrial Partners on Spanish company Grifols SA helped the hedge fund earn double-digit gains…
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Grifols S.A. - GRFS
NEW YORK, March 31, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of…
Grifols S.A. (GRFS – ADR ADR Class B) Shares Decline Again After Gotham City Research Issues Another Critical Report – Hagens Berman
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages GRFS American Depositary Receipt Investors with Substantial Losses to Contact Firm HAGENS BERMAN, NATIONAL…
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Grifols S.A. - GRFS
NEW YORK, March 23, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of…
Grifols’ Financials Have No Big Errors, Spanish Regulator Says
Spanish securities regulators said they didn’t find any big mistakes in Grifols SA’s financial reports, though the pharmaceutical company does…
Grifols Shares Jump as Auditor Greenlights Annual Accounts
Grifols SA shares rallied from multiyear lows after an auditor signed off on the annual accounts of the Spanish plasma…
Grifols Analysts Are Losing Faith After Disappointing Guidance
In the weeks following a short seller attack earlier this year, analysts mostly stood behind Spanish blood plasma firm Grifols…
GRFS Investigation Alert: Kessler Topaz Meltzer & Check, LLP Encourages Grifols S.A. (NASDAQ: GRFS) Investors with Significant Losses to Contact the Firm
RADNOR, Pa., March 01, 2024 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP…